Genetically Modified T Cells Obliterate Chronic Lymphocytic Leukemia Tumors

Posted: September 9, 2011 at 1:10 pm

This post was added by Dr P. Richardson


Video Download: YouTube Video Here


Researchers at Penn's Abramson Cancer Center have molecularly engineered T-cells from patients with chronic lymphocytic leukemia and achieved an exceptional, unprecedented antitumor response. In the pilot study of three patients, two achieved complete remission and the third experienced remarkable antitumor response, which was impossible with previously available treatments.

See original here:
Genetically Modified T Cells Obliterate Chronic Lymphocytic Leukemia Tumors

Related Post
This entry was posted in Cell Medicine. Bookmark the permalink.

Comments are closed.